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1.0 INTRODUCTION 
The concept of rapid dispersible, fast dissolving, quick 
dissolving, and orodispersible tablets dosage forms have 
acquired great importance in recent years due to their 
unique properties and advantages over other available 
dosage forms.1, 2  In the recent years, great interests in the 
modification of drug release by using various methods such 
as solid dispersion, particle size reduction, micronization, 
direct compaction method, melt granulation techniques, 
solvent deposition inclusion complexation methods were 
adopted in formulation.3 The basic goal behind all of such 
innovations include developing a suitable formulation with 
rapid release of poorly water-soluble drugs.4   
Nearly one-third of drugs in development are water 
insoluble and one-half fail in trials because of 
underprivileged pharmacokinetics.5 Tolfenamic Acid also 
falls in the same category, the basic challenge in 
formulation of Tolfenamic acid is its poor solubility.6 
Tolfenamic Acid is an orally and parenterally administered 
Non – steroidal anti-inflammatory drug belonging to the 
fenamate group.7 Since the Tolfenamic acid is poorly water 
soluble drug so the dissolution is the rate limiting step for 
the absorption of drug. The Tolfenamic acid was originally 
formulated as  hard gelatin capsules probably because of 
difficulties in preparing  tablet being a reasonable size and 
rapid disintegration of active in compressed dosage form, 
with suitable size that can be easily swallowed by patients.8 
There are various approaches for improvement of release 
profile by application of various techniques such as solid 
dispersion,9 by using surfactants,10 and size reduction8 of 
Tolfenamic acid is reported in the various literature and 
patents.  
Nowadays Co- micronization of active with specific 
excipients becomes interesting approach to enhance the 
release profile of poor water soluble compounds.11, 12, 13 
Tolfenamic acid is insoluble in nature, therefore in present 
study efforts were made to improve the release profile of 
active and to formulate rapid dispersible tablets of 
Tolfenamic acid by using novel concept of co-
micronization.  
2.0 MATERIALS  
Tolfenamic Acid was a gift sample from Elder 
Pharmaceuticals Ltd, Navi Mumbai, India. Aspartame and 
Flavor Vanilla was a gift sample from Cadila 
Pharmaceuticals Limited, Ahmadabad, India. 
Microcrystalline cellulose, Sodium Lauryl sulfate, 
Povidone, Mannitol, and sodium starch glycolate were 
obtained from commercial sources. 
3.0 METHODS  
The basic aim of the study was to enhance the release 
profile of Tolfenamic acid by using co-micronization 
concept. Approximately 1% of disintegrants was added to 
make dispersion and wetting of tablets but it did not had a 
greater impact on dissolution enhancement. The details of 
formulations were summarized in the table-1.   
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Table 1: Formulation details of Rapid Dispersible Tablets of TA 
Ingredients Quantity available in each tablets (mg/tabs) 
 A-1 A-2 A-3 A-4 
Intra-granular     
Tolfenamic Acid 100.00 100.00 100.00 100.00 
Microcrystalline Cellulose 80.000 80.000 81.250 80.000 
Sodium Lauryl Sulfate 1.250 1.250 -- 1.250 
Povidone (PVP K-30)  2.500 2.500 2.500 2.500 
Purified Water QS QS QS QS 
Extra-granular     
Mannitol 45.000 45.000 45.000 45.000 
Sodium Starch Glycolate 2.500 2.500 2.500 2.500 
Magnesium Stearate 1.250 1.250 1.250 1.250 
Aspartame 5.000 5.000 5.000 5.000 
Flavor Vanilla 2.500 2.500 2.500 2.500 
Tablet Weight in mg 240.00 240.00 240.00 240.00 
 
3.1 Solubility Enhancement of Tolfenamic Acid and its 
evaluation 
Total four formulations were designed to evaluate the effect 
of the co-micronization on the dissolution and dispersion 
properties of finished product. Formulation A-1 was 
manufactured with non micronized Tolfenamic acid as 
reference to check the impact of co-micronization on the 
various physico-chemical properties of formulation. 
3.1.1 Manufacturing of Co-micronization blend
24
  
The co-micronization of Tolfenamic Acid and diluents as 
per the given details of formulation in Table -2 was done by 
using Air-jet mill (Shree Engineering). Total three cycle of 
micronization was completed to insure the proper particle 
size reduction of blend. Micronization of formulation A-1 
was not done; but sifting of Tolfenamic acid (non-
micronized) of Formulation A-1 was done through #60 
meshes to insure the uniformity of Tolfenamic acid in 
blend.  
Table 2: Preparation of Co-micronization blend for solubility enhancement 
Formulation A-1 A-2 A-3 A-4 
Processing 
Simple mixing of un-
micronized TA with MCC 
and SLS for reference 
Micronization of TA 
and mixing with MCC 
and SLS 
Co-micronization of 
TA and MCC. 
Co-micronization of 
TA, with MCC & SLS. 
 
 
3.1.2 Physical evaluation of Co-micronization blend 
The evaluation of micronized mixtures of Formulation A-1 
to A-4 was confirmed for particle size of TA mixture. The 
particle size was evaluated by using Malvern Mastersizer 
2000. The average particle size which was the mean particle 
size of 90% (d-0.9) of particle in sample was recorded for 
evaluation.14  
3.2 Manufacturing of Granules
25
 
Co-micronized blend of Tolfenamic acid was mixed in rapid 
mixer granulator (HSMG-10, Kevin Machinery) with slow 
impeller speed (75 RPM) for 10 minutes, PVP K-30 was 
dissolved in distilled water to give a binder concentration of 
6.0 % w/v. To granulate, the binder was added slowly over 
five minutes through a glass funnel to control the flow rate. 
The resultant material was wet massed through the required 
sieve. Granules were vacuum dried using vacuum dryer 
(Shree Engineering) at 55°C for 150 – 180 minutes. In 
addition to the temperature and the duration of the drying 
process, the moisture content and flow rate of the 
circulating air could affect granule strength and therefore to 
standardize, the amount of granules in each tray-dried was 
kept within an approximate range of 600-900g. The residual 
granule moisture content was determined by loss on drying. 
Granules were stored in double polythene bags until use to 
prevent moisture loss / gain. The dried granules than 
blended with extra granular excipients as per the given 
details of formulation in table – 1 using  bin blender (Solace 
Engineering) at 12 RPM for 10 minutes. The blends were 
lubricated with Magnesium Stearate using bin blender at 12 
RPM for 3 minutes.   
3.3 Manufacturing of Tablet
25
 
The compression of granules was completed by using 
Cadmach single rotary compression machine. 9.00 mm 
FFBE chrome plated punching tools was used to avoid any 
sticking problem during compression. The average turret 
speed during compression was also kept in range of 10 – 12 
RPM. In preliminary work, problems with uncontrolled 
moisture sorption occurred in granules during tabletting. 
Highly variable moisture contents made direct effect on 
physical properties of tablets. The relative humidity of the 
tabletting area monitored during compression of tablets. The 
higher humidity had significant effect on tablets properties, 
so a limit of 50% RH was set as the maximum relative 
humidity at which tabletting was carried out. 
3.4 Physical Evaluation of Granules 
3.4.1 Loss on drying
15 
Loss on drying is the loss of weight expressed as percentage 
w/w resulting from water and volatile matter of any kind 
that could be driven off under specified conditions. The loss 
on drying was calculated by using equation,  
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 Approximately 2.0 gms of dried granules were placed on 
aluminum disk of IR moisture balance. The loss on drying 
was recorded at 1050C for 10 minutes of time interval.  
3.4.2 Tapped and Untapped Density
15, 16 
Un-tapped and tapped density was determined by placing a 
graduated cylinder containing a known mass of drug on a 
mechanical tapper apparatus which was operated for fixed 
number of taps (~ 100) until a powder bed volume had 
reached the minimum. The ratio of mass (weight) to volume 
is known as the untapped bulk density of material. The bulk 
density of a powder depends on particle size distribution. 
The equation for determining the bulk density and tapped 
density is, 
 
 
Where, „ρb‟ is untapped bulk density, „ρt‟  is tapped density 
, „M‟ is weight of sample in grams, „Vp‟ i s  final volumes 
of powder in cm3, „Vt‟ is tapped volume of powder in cm3. 
3.4.3 Compressibility Index
15, 16 
The compressibility index of the granules was determined by 
Carr‟s index. The Carr‟s index was determined from the 
tapped density and poured density (bulk density) as per the 
formula given below, 
 
3.4.4 Hausner Ratio
16 
Hausner Ratio was determined from the ratio of tapped 
density to bulk density using formula given below.  
 
Flow of granules was evaluated by using interpretation 
between Hausner Ratio and carr‟s index as shown in table 3
Table 3: Interpretation by Hausner Ratio. 
Hausner’s Ratio Interpretation Equivalent Carr’s Index 
1.25 Good flow 20% 
>1.25 Poor flow 33% 
  
3.4.5 Angle of repose
15, 16 
Angle of repose of samples were measured by employing 
fixed height method, the specific amount of sample was 
poured through the funnel from the height of 2cm. The 
diameter of pile formed was measured and angle of repose 
was calculated by using following formula, 
 
Where, „θ‟ is angle of repose, „h‟ is height, and „r‟ is radius. 
The flow properties of granules were than interoperated by 
using table as shown in table – 4. 
Table – 4: Interpretation of angle of repose 
Flow Properties Angle of Repose 
Excellent 25-30 
Good 31-35 
Fair-aid not needed 36-40 
Passable-may hang up 41-45 
Poor-must agitate, vibrate 46-55 
Very poor 56-65 
 
3.5 Physical Evaluation of Tablets 
3.5.1 Appearance 
Appearance of tablets was evaluated by taking twenty 
tablets of each formulation and visually checked for any 
discoloration or surface roughness on the core surface of 
tablet formulation. 
3.5.2 Weight Variation of tablets 
16, 17 
Weight variation of tablets was calculated by weighing 20 
tablets individually and determining the average weight. 
Tablet meets the test if not more than two of the individual 
weights deviate from percentage limits of 7.5%.17    
3.5.3 Hardness
16, 18
  
The hardness of six tablets was determined using the 
Erweka type hardness tester and the average values were 
calculated for each formulation trials. 
3.5.4 Thickness
18
  
The Thickness of the tablets was determined by using 
Digital vernier calipers (Mitutoyo, Japan). Six tablets were 
used, and average values were calculated for each 
formulation trials. 
3.5.5 Friability
16 
It was intended to determine the loss of mass under defined 
conditions. The friability of uncoated tablets was 
determined by using Electro lab Friability Apparatus. The 
20 pre weighed tablets were paced in friability apparatus 
and tested for the effects of abrasion and shock by utilizing 
a plastic chamber that revolves at 25 rpm dropping the 
tablets at a distance of six inches with each operation for 
100 revolutions. The tablets are then de dusted and 
reweighed. The percentage for friability than calculated 
using following formula, 
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As per the Indian pharmacopoeia the limit for friability 
tablets should not be more than 1% w/w.17 The  values  for  
both  Hardness  &  Friability  can  together  indicate  the  
mechanical strength of tablet.19  
3.5.6 Disintegration Time 
Disintegration is defined as time required by tablet to 
completely disintegrate and disappear from the basket. 
Disintegration time of tablets was evaluated as per the 
specification of disintegration time of dispersible and 
Orodispersible tablets in British pharmacopoeia.20 
Disintegration was carried out by using 600ml of 
disintegration media mentioning the temperature at 150C – 
250C in disintegration basket.18 Disintegration discs were 
not used during disintegration. The use of discs during 
disintegration reduces discrimination between good and bad 
formulations since the palpable residue on the mesh would 
not pass through without applying pressure and thus 
violating the principle of fluid penetration and particle 
separation.21  
3.5.7 In vitro dispersion Time and Fineness of 
Dispersion 
Fineness of dispersion is specified in the specification of 
dispersible tablets .20, 22 This taste is required to check the 
fineness and smoothness of dispersion of tablets. The same 
concepts were applied to correlate the dispersion of tablets 
in vivo by using pH 6.8 phosphate buffer. The in vitro 
dispersion time was observed by placing one tablet in a 
beaker containing 50 ml of pH 6.8 phosphate buffer at 370C 
+ 10C, the time required to disperse the tablets was 
determined.23 The same dispersion was passed through a 
sieve screen with a nominal mesh aperture of 710 mm to 
confirm the fineness of dispersion. 
3.5.8 Wetting Time and Water Absorption Ratio 
Water absorption ratio of tablet was evaluated by using 
aqueous solution of Methylene Blue. It is also an indicating 
method to evaluate the disintegrating mechanism of 
tablets.18 Absorbent cotton soaked with 0.04 % aqueous 
solution of methylene blue was placed in a Petri dish, the 
tablets was placed flat on the surface of cotton, and the time 
required to change the color of whole tablets to blue was 
measured as water absorption time. Total six tablets were 
used for the investigation of water absorption time and 
mean of water absorption time was calculated.19   
Water absorption ratio (WAR) was calculated by using the 
pre weight and post weight of tablet used for wetting time 
evaluation by using following equation,
 
 
3.6 Analytical Evaluation of Tablets 
3.6.1 Assay of drug content in Tablets
20, 22
  
The analysis for drug content of formulation was developed 
based on monograph of Tolfenamic acid in British 
pharmacopoeia.20  
Standard Preparation 
Weigh accurately & transfer about 150 mg of Tolfenamic 
acid in 100 ml   volumetric flask, dissolve it in 50ml of 0.1 
M NaOH & dilute up to mark with 0.1 M NaOH. Dilute 1 
ml of the solution to 100 with 0.1 M NaOH.  
Sample Preparation  
The assay of each formulation was evaluated by taking 
twenty tablets and crushing the tablets by using Petri dish. 
240 mg equivalent weight of powdered Tolfenamic acid 
was taken in to a 100 ml volumetric flask. Add 80 ml of 0.1 
M NaOH. Shake for 30 minutes, dilute to 100 ml with 0.1 
M NaOH. Filter, discarding the first few ml of the filtrate 
and dilute 1 ml of this solution to 100 ml with 0.1 M NaOH. 
Measure the absorbance of sample and standard preparation 
at 289 nm using 0.1 M NaOH as the blank with UV 
Spectrophotometer (Shimadzu). Calculate content of 
Tolfenamic acid per tablets, by following formula;  
 
 
3.6.2 In-vitro drug release kinetics
20, 22 
In-vitro dissolution studies of all formulation were evaluated 
for the release profile of formulation. The basic objective of 
formulation was to develop the rapid disintegrating 
formulations, so release profile at various time intervals such 
as 5, 10, 15, 30, 45, and 60 minutes were analyzed for the 
evaluation of release kinetics.   
USP dissolution apparatus    : Type-II Paddle, 
100 RPM 
Dissolution Medium  : 1000 ml, 
Phosphate Buffer pH 7.2 
Temperature   : 37 ± 0.5 0C 
Sampling Times (minutes)   : 5, 10, 15, 30, 
45, and 60 
Preparation of Dissolution Medium 
Take 250 ml of ethanol 96 % and dilute to 1000 ml with 
Phosphate Buffer pH 7.2. 
Preparation of Phosphate Buffer pH 7.2 
Dissolve 40.8 g of Potassium dihydrogen phosphate in 1500 
ml of distilled water and adjust pH to 7.2 with 40% NaOH 
and then dilute to 4500 ml with water.  
Preparation of Standard solution 
Weigh accurately & transfer about 100mg of Tolfenamic 
acid in a 500 ml volumetric flask. Dissolve in 250ml 0.1M 
NaOH & dilute up to mark with 0.1 M NaOH. Dilute 1ml of 
resulting solution to 25 ml with 0.1M NaOH. 
Dissolution Procedure
8
  
Dissolution of tablets was initiated by placing one tablet in 
each of six vessels containing 1000 ml dissolution medium, 
using paddle apparatus at 100 rpm for 60 minutes. 5 ml of 
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the sample solution was withdrawn from the dissolution 
beaker as per the given time interval and replacing the same 
volume by addition of dissolution media. The absorbance of 
sample solution and standard solution was measured by 
using UV Spectrophotometer (Shimadzu) at the maximum 
about 289 nm using 0.1M NaOH as blank. 
4.0 RESULT AND DISCUSSION 
4.1 Physical evaluation of Co-micronization blend 
The average particle size which is the mean particle size of 
90% (d-0.90) of particle in sample was recorded for 
evaluation ad tabulated in the table – 5.  
Discussion 
The average particle size of reference formulation (un-
micronized) formulation A-1 was 161.625µm, and average 
particle size of micronized and co-micronized blend for 
formulation A-2, A-3, and A-4 were approx 10µm, which 
was reflecting an effective particle size reduction using Air 
jet mill. 
Table - 5: Particle size distribution after micronization 
Formulation Average Particle Size (d-0.90) in µm Particle Size (d-0.50) in µm Particle Size (d-0.10) in µm 
A-1 161.625 53.675 9.621 
A-2 10.926 6.256 3.256 
A-3 9.856 6.958 3.125 
A-4 10.214 5.935 2.968 
 
4.2 Physical Evaluation of Granules 
The various physical evaluation for granules of formulation A-1 to A-4 is summarized in table - 6. 
Table – 6: Physical properties of granules (n=3) 
Physical Properties A-1 A-2 A-3 A-4 
Qty of water uptake during 
granulation (ml) 
Nil 10 14 17 
Loss on drying (%w/w) 1.42 ± 0.312 1.513 ± 0.031 1.640 ± 0.050 1.600 ± 0.020 
Bulk density (gm/ml) 0.55 ± 0.010 0.500 ± 0.017 0.523 ± 0.006 0.530 ± 0.010 
Tapped density (gm/ml) 0.683 ± 0.015 0.637 ± 0.012 0.627 ± 0.021 0.623 ± 0.006 
Carr‟s Index (%) 19.500 ± 1.407 21.481 ± 1.283 16.448 ± 1.874 14.968 ± 1.793 
Hausner‟s Ratio 1.242 ± 0.022 1.274 ± 0.021 1.197 ± 0.027 1.176 ± 0.025 
Angle of Repose 33.33 ± 0.58 36.667 ± 0.577 31.667 ± 0.577 30.333 ± 0.577 
 
Discussion 
The additional quantity of water during granulation was 
noted in all four formulations, 10, 14, and 17 ml additional 
uptake of water was required in formulation A-2, A-3, A-4. 
This might be due to increased surface area of particle due 
to co-micronization of Tolfenamic acid, and Tolfenamic 
acid with diluents. The same tendency of additional drying 
was observed during drying of granules, the loss on drying 
for formulation A – 3 & A – 4 was 1.60 and 1.64 % W/W, 
as compare to loss on drying of formulation A – 1, and A – 
2; 1.42 and 1.513 % w/w. 
Angle of repose was evaluated to confirm the flow of 
granules, the values of angle of repose was found in the 
range of 30 – 36 indicating a fair to good flow of granules. 
The effect of micronization clearly reflecting in the 
compressibility index of granules, which is the basic 
requirement of compression, the co-micronization 
processing of formulation A-3 and A-4 showed good 
compressibility index in the range of 15 – 16. The same 
observation also reflecting in housner‟s Ratio of granules.  
So on the basis of various physical properties of granules; it 
was clearly indicating the justified selection of intra 
granular diluents such as microcrystalline cellulose and wet 
granulation of co-micronized granules to avoid any weight 
variation problem, die filling problem, and flow problem 
during compression of tablets. 
4.3 Physical evaluation of tablets 
The various physical evaluation for tablets of formulation 
A-1 to A-4 is summarized in table - 7. 
Table 7: Physical evaluation of tablets 
Evaluation Parameters A-1 A-2 A-3 A-4 
Appearance Off-white colored, 9.0± 0.1 mm, round flat faced tablet 
Weight Variation (%) 241.56± 2.35 241.34± 1.93 241.01± 2.46 240.85± 2.29 
Hardness (Newton) n=6 28.67± 2.50 30.00± 2.10 33.33± 2.16 35.00± 1.26 
Thickness (mm) n=6 3.20± 0.01 3.18± 0.02 3.20± 0.02 3.19± 0.02 
Friability (% w/w) 0.65 0.68 0.72 0.69 
Disintegration (Seconds) 15 – 20 18 – 22 15 - 20 17– 22 
Dispersion (Seconds) n=3 50.67± 1.15 43.67± 1.53 43.67± 1.00 40.00± 3.00 
Wetting Time (Seconds) n=3 65.00± 3.00 55.00± 2.00 43.67± 1.53 40.00± 2.00 
Water Absorption Ratio 53.17 55.79 61.82 66.08 
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Discussion 
The appearance of tablets found good without any 
significant defects (figure – 1). Weight variation data for all 
the formulations batches indicated no significant difference 
in the weight of individuals tablets from the average value 
and weight variation were found to be within limits. The 
value of hardness friability of tablet showed good strengths 
in all formulation, which is an essential parameter for 
formulation of rapid dispersible tablets. The thickness of 
tablets was also within limit. 
Disintegration time for all formulation was in range 
between 15 and 22 seconds, which is required to formulate 
ideal rapid dispersible tablets. There was some significant 
difference observed in dispersion and  wetting time of 
formulation, the dispersion time and wetting time was 
higher for formulation A-1 and A-2 as compare to 
formulation A-3 and A-4. The rapid dispersion and wetting 
reflects the effect of co-micronization of blend during 
granulation stage. The co-micronization of blend was 
increasing the surface area of compressed blend during 
dispersion and wetting. The dispersion and wetting time 
was lowest for the formulation A-4, indicating the clear 
impact of wetting properties of sodium Lauryl sulfate in 
formulation. The co-micronization of sodium Lauryl sulfate 
with active and diluents increasing the wetting properties of 
granules. Same phenomenon of rapid dispersion and wetting 
reflects in water absorption ratio of formulation A-4. The 
water absorption ratio for formulation A-4 and A-3 was 
very less as compare to A-1 and A-2.  So there is clear 
impact of co-micronization in enhancement of physical 
properties of formulations. Since the present study was 
focused on the enhancement of release profile of 
formulation, still there were possibilities of enhancing the 
dispersion and wetting time by using more concentration of 
superdisintegrants. The diagrammatic presentation of 
dispersion and wetting of tablets is shown in figure – 2 and 
3.   
 
 
 
Figure 1: Appearance of Tablets 
  
Figure  2: Dispersion of Tablets Figure 3: Wetting of Tablets 
4.4 Analytical Evaluation of Tablets 
The assay of drug content and in vitro drug release profile for tablets of formulation A-1 to A-4 is summarized in table – 8 
and 9. 
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Table 8: Assay of drug content in tablets 
Evaluation Parameters A-1 A-2 A-3 A-4 
Drug Content (%) n=3 100.97± 1.75 100.30± 1.97 100.80± 1.73 100.33± 1.63 
Content Uniformity ( %) n=10 Passed Passed Passed Passed 
Discussion 
The drug content of tablets and content uniformity of tablets 
for all formulation A-1 to A-4 was well within the limits. 
There was no significant variation observed due to co-
micronization and simple mixing of blend at granulation 
stage.  
 
 
Figure 4: Effect of co-micronization on release profile of formulations 
Discussion 
The rate of drug release was found to be related to the co-
micronization process of the formulations. The release of 
formulations A-1, A-2, A-3, A-4 is 40, 55, 79, and 82 % 
respectively . The release profile after 15 minutes for 
formulation A-1, A-2, A-3, A-4 is 67, 76, 89, and 92 % 
respectively. There was no significant difference observed 
after 30 minutes of dissolutions studies. Among all 
formulation A-3 and A-4 showed more than 90% release of 
active within 15 minutes of dissolution. The rapid release of 
about 80% of medicament was observed in formulation A1, 
and A-2, which differentiated it from the remaining 
formulation such as A-1 and A-2. The effect of co-
micronization on the release profile of formulation also 
shown in figure - 4.  The effect of micronization also 
reflecting in formulation A-2, but the co-micronization of 
active with diluents was fulfilling the basic aim of 
development of rapid dispersible tablets of Tolfenamic acid.  
 
 
 
CONCLUSION 
On the basis of various physical and analytical evaluation of 
formulation the rapid dispersion and wetting of formulation 
can easily achieved by simple incorporation of 
micronization of active with diluents. The co-micronization 
showed a promising effect in the particle size reduction of 
Tolfenamic acid and providing more surface area in 
enhancement of wetting and dispersion properties of 
formulations. The comparative evaluation of formulation A-
1 (as reference formulation without micronization of active) 
proved the concepts of co-micronization in the Tolfenamic 
acid rapid dispersible tablets. The rapid release of 
formulation which was the basic requirement of rapid 
dispersible tablets also achieved by using co-micronization 
approach during manufacturing of granules.     
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